U.S. Stock News

SL Green Realty (NYSE:SLG) has agreed to sell the residential and retail components of 7 Dey Street. The company reports that One Madison Avenue is now fully leased. SL Green also highlights significant Manhattan leasing activity so far this year. For investors watching NYSE:SLG, these updates come at a time when the stock trades at $38.37 and has seen very different returns over various time frames, with a 1.5% gain over the past week alongside a 31.8% decline over the past year and a...

Nordic American Tankers (NYSE:NAT) has agreed to sell a 2005 built vessel for around US$40 million. Management describes the transaction as aligned with the company’s current positioning and plans for future fleet growth. The deal affects fleet composition and adds flexibility around capital allocation going forward. The sale comes as Nordic American Tankers trades at a share price of US$5.42, with the stock up 3.4% over the past week and 19.4% over the past month. Returns of 60.8% year to...

General Mills (GIS) has just posted its Q3 2026 numbers, with revenue at US$4.4b and basic EPS of US$0.57, set against a trailing twelve month EPS of US$4.07 on revenue of US$18.4b. Over recent quarters the company has seen revenue move from US$4.8b in Q2 2026 and US$4.5b in Q1 2026 to the latest US$4.4b print, while basic EPS shifted from US$0.77 and US$2.22 in those periods to US$0.57. This sets up a results season where investors are likely to focus squarely on how margins are holding up...

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...

Palomar Holdings (NasdaqGS:PLMR) reported strong fourth quarter results, with revenue figures that were materially ahead of earlier analyst expectations. The quarter highlighted performance in the company’s catastrophe insurance focus, an area closely watched by investors given recent weather and loss events. This update reflects current operating momentum for Palomar’s specialty insurance franchise and has not been widely discussed in recent coverage. Palomar focuses on specialty and...

In March 2026, Gambling.com Group reported that fourth-quarter 2025 sales rose to US$46.24 million and full-year 2025 sales reached US$165.45 million, but the company swung to a full-year net loss of US$32.93 million after recording a US$14.01 million impairment on intangible assets. Alongside these results, the company completed a share buyback of 3,960,663 shares for US$35.58 million and issued 2026 revenue guidance of US$170 million to US$180 million, highlighting a growing focus on data...

Protalix BioTherapeutics FY 2025 Earnings Snapshot Protalix BioTherapeutics (PLX) has wrapped up FY 2025 with fourth quarter revenue of US$9.1 million and a basic EPS loss of US$0.07, as investors weigh the latest numbers against the share price of US$2.21. The company has seen quarterly revenue move from US$18.2 million in Q4 2024 to US$10.1 million in Q1 2025, US$15.7 million in Q2 2025, US$17.9 million in Q3 2025 and US$9.1 million in Q4 2025. Basic EPS shifted from US$0.09 in Q4 2024 to...

Gossamer Bio (GOSS) has just closed out FY 2025 with fourth quarter revenue of about US$13.8 million and a basic EPS loss of US$0.21, alongside a trailing twelve month EPS loss of US$0.75 on revenue of US$48.5 million. This sets a clear snapshot of where the business stands heading into 2026. Over recent quarters the company has seen revenue move from US$9.4 million in Q4 2024 through US$9.9 million, US$11.5 million and US$13.3 million to US$13.8 million in Q4 2025, while quarterly EPS losses...

Spire Global (SPIR) closed out FY 2025 with Q4 revenue of US$15.8 million, a basic EPS loss of US$0.76, and a net loss of US$25.1 million, against a backdrop of trailing 12 month revenue of US$71.6 million and basic EPS of US$1.66. Over recent quarters the company has seen quarterly revenue range from US$23.9 million in Q1 2025 to US$12.7 million in Q3 2025, while quarterly EPS has swung between a US$3.80 profit in Q2 2025 and losses such as US$1.90 in Q4 2024. This sets up a complex picture...

ClearPoint Neuro (CLPT) just posted its FY 2025 numbers with Q4 revenue of US$10.4 million, a basic EPS loss of US$0.27, and trailing twelve month revenue of US$37.0 million alongside a trailing EPS loss of US$0.90. Over recent periods, the company has seen quarterly revenue move from US$7.8 million in Q4 2024 to US$10.4 million in Q4 2025, while quarterly EPS losses shifted from US$0.20 to US$0.27 over the same stretch. For investors, the update sets solid top line progress against ongoing...

Ovid Therapeutics (OVID) closed FY 2025 with fourth quarter revenue of US$0.72 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$7.25 million and a trailing basic EPS loss of US$0.24. Over the past year, the company has seen quarterly revenue move from US$0.08 million in Q4 2024 to US$6.27 million in Q2 2025 and US$0.72 million in Q4 2025. Basic EPS has ranged from a loss of US$0.20 in Q3 2024 to a loss of US$0.17 in Q3 2025 and a profit of US$0.12 in Q4 2025...

Andersen Group FY 2025 earnings snapshot Andersen Group (ANDG) has just wrapped up FY 2025 with fourth quarter revenue of US$170.3 million, a basic EPS loss of US$0.18, and trailing twelve month revenue of US$838.7 million, alongside a trailing net margin of 6.9% versus 18.5% a year earlier. Over the last six reported quarters, revenue has moved from US$639.1 million on a trailing basis in FY 2023 to US$838.7 million in FY 2025. Quarterly net income has swung between profit and loss as...

Energy Vault Holdings (NRGV) has posted its FY 2025 numbers with fourth quarter revenue of US$153.3 million and a net loss of US$20.7 million, translating to basic EPS of a US$0.12 loss. On a trailing twelve month basis, revenue sits at US$203.7 million with a net loss of US$103.6 million and basic EPS of a US$0.65 loss. The company’s revenue has moved from US$33.5 million in Q4 2024 to US$153.3 million in Q4 2025, with quarterly basic EPS shifting from a US$0.43 loss to a US$0.12 loss over...

Lifeway Foods (LWAY) just wrapped up FY 2025 with Q4 revenue of US$55.4 million and basic EPS of US$0.17, capping a year in which trailing twelve month revenue reached US$212.5 million and EPS came in at US$0.91. Over the past few quarters, revenue has moved from US$46.1 million in Q1 2025 to US$57.1 million in Q3 and then US$55.4 million in Q4, while quarterly EPS ranged between US$0.17 and US$0.28. This sets the stage for investors to focus on how margins are holding up through this...

Titan America (TTAM) FY 2025 earnings snapshot Titan America (TTAM) has wrapped up FY 2025 with fourth quarter revenue of US$405.7 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$1.7 billion and EPS at US$1.01, alongside earnings growth of 11.7% over the last year. The company has seen quarterly revenue move from US$389.8 million in Q4 FY 2024 to US$405.7 million in Q4 FY 2025, with quarterly EPS shifting from US$0.21 to US$0.24 as trailing net income...

Adecoagro (NYSE:AGRO) closed out FY 2025 with Q4 revenue of US$415.9 million and a basic EPS loss of US$0.14, as net income excluding extra items came in at a loss of US$15.4 million. The company has seen quarterly revenue range from US$304.2 million to US$415.9 million over 2025, while EPS has swung between a loss of US$0.18 and a profit of US$0.18, underscoring how sensitive margins remain to operating conditions. See our full analysis for Adecoagro. With the headline numbers set, the next...

Kestra Medical Technologies (KMTS) has just posted its latest quarterly update with Q2 2026 revenue of US$22.6 million and a basic EPS loss of US$0.64, alongside a trailing 12 month EPS loss of US$3.44 on revenue of US$74.3 million that highlights the current earnings profile. The company has seen quarterly revenue move from US$14.7 million in Q2 2025 to US$22.6 million in Q2 2026. Over the same period, quarterly basic EPS losses have shifted from US$1.19 in Q2 2025 to US$0.64 in Q2 2026,...

Abeona Therapeutics (ABEO) closed FY 2025 with Q4 revenue of US$5.4 million and basic EPS of a US$0.37 loss, alongside a net income loss of US$20.5 million. Its trailing twelve month figures show basic EPS of US$1.34 and net income of US$71.2 million on revenue of US$5.8 million. Over recent quarters the company has reported revenue of US$0 in Q3 2025, US$0.4 million in Q2, and US$5.4 million in Q4, with quarterly basic EPS moving from a US$2.07 profit in Q2 to losses of US$0.10 in Q3 and...

With Hawaiian Electric Industries trading at around US$14.49, this article explores whether the stock might represent a bargain or a value trap by walking through key aspects of the current valuation. The stock has returned 14.7% year to date and 31.6% over the last year, while 3 year and 5 year returns show declines of 60.5% and 62.1%. This contrast may leave you considering how to weigh recent momentum against longer term performance. Recent headlines around Hawaiian Electric Industries...

Why the latest earnings and buyback matter for Village Farms International (VFF) Village Farms International (NasdaqCM:VFF) has drawn fresh attention after reporting fourth quarter and full year 2025 results that show net income for both periods, alongside completion of a US$2.98 million share repurchase program. See our latest analysis for Village Farms International. Despite turning net income positive for both the quarter and full year and completing the US$2.98 million buyback, Village...

Tencent Music Entertainment Group (NYSE:TME) just put fresh numbers on the board for FY 2025, with third quarter revenue of C¥8.5b and basic EPS of C¥1.40, set against the backdrop of trailing twelve month revenue of C¥31.7b and EPS of C¥7.05. Over recent quarters, revenue has moved from C¥7.0b in Q3 2024 to C¥7.5b in Q4 2024, C¥7.4b in Q1 2025, C¥8.4b in Q2 2025 and now C¥8.5b in Q3 2025. Quarterly EPS tracked from C¥1.02 to C¥1.27, C¥2.81, C¥1.57 and C¥1.40 over the same stretch. For...

Freshpet has permanently revised its dog food advertising to remove or clarify "human grade" claims following a review by the National Advertising Division. The changes come after a recent regulatory challenge that focused on how clearly the company described the quality standards of its pet food. The updated claims reflect Freshpet's decision to align its marketing more closely with industry advertising guidelines. For investors watching NasdaqGM:FRPT, the move comes at a time when the...

Exact Sciences stock snapshot Exact Sciences (EXAS) has drawn investor attention after recent share price moves, with the stock near US$103.94 and return figures over the past year and past 3 years standing out against its 5 year record. See our latest analysis for Exact Sciences. The recent move in Exact Sciences' share price to around US$103.94 comes after a strong 1 year total shareholder return of 131.39%. However, the 5 year total shareholder return shows a decline of 21.26%, indicating...

MakeMyTrip (NasdaqGS:MMYT) is drawing increased market attention as institutional investors adjust their exposure to the stock. The company is expanding its digital travel platform, with recent activity focused on broadening services and reach across online travel segments. These developments are being closely watched by market participants assessing the company’s role in the wider global travel ecosystem. MakeMyTrip operates a digital travel platform that connects users with flights,...